1.
Rev. bras. anestesiol
;
44(1): 83-90, jan.-fev. 1994. ilus
Article
in Portuguese
| LILACS
| ID: lil-166629
Subject(s)
Anti-Arrhythmia Agents/administration & dosage , Anti-Arrhythmia Agents/adverse effects , Anti-Arrhythmia Agents/pharmacokinetics , Anti-Arrhythmia Agents/pharmacology , Disopyramide , Flecainide/administration & dosage , Flecainide/adverse effects , Flecainide , Flecainide/pharmacokinetics , Lidocaine/administration & dosage , Lidocaine , Lidocaine/adverse effects , Lidocaine/pharmacokinetics , Procainamide/administration & dosage , Procainamide/adverse effects , Procainamide , Procainamide/pharmacokinetics , Quinidine/administration & dosage , Quinidine/adverse effects , Quinidine , Quinidine/pharmacokinetics
2.
Rev. bras. reumatol
;
30(1): 13-9, jan.-fev. 1990. tab
Article
in Portuguese
| LILACS
| ID: lil-81222
ABSTRACT
Os autores fazem uma revisäo da literatura quanto as manifestaçöes reumáticas induzidas por drogas. Salientam e questionam alguns dos mecanismos envolvidos nas reaçöes adversas as drogas e sua manifestaçöes clínico-laboratoriais, dando enfase ao lúpus-símile. Além disso, alertam sobre a importância em se detectar iatrogenia no curso de uma terapêutica medicamentosa
Subject(s)
Humans , Anticonvulsants/adverse effects , Captopril/adverse effects , Chlorpromazine/adverse effects , Contraceptives, Oral/adverse effects , Griseofulvin/adverse effects , Hydralazine/adverse effects , Isoniazid/adverse effects , Penicillamine/adverse effects , Penicillins/adverse effects , Practolol/adverse effects , Procainamide/adverse effects , Rheumatic Diseases/chemically induced
3.
Rev. méd. Chile
;
117(7): 804-12, jul. 1989. tab, ilus
Article
in Spanish
| LILACS
| ID: lil-69875
Subject(s)
Humans , Phenelzine/pharmacokinetics , Procainamide/pharmacokinetics , Sulfasalazine/pharmacokinetics , Dapsone/pharmacokinetics , Hydrazines/pharmacokinetics , Isoniazid/pharmacokinetics , Phenelzine/adverse effects , Procainamide/adverse effects , Sulfasalazine/adverse effects , Dapsone/adverse effects , Hydrazines/adverse effects , Isoniazid/adverse effects , Drug Evaluation , Genetic Markers
4.
Rev. bras. reumatol
;
27(6): 205-8, nov.-dez. 1987.
Article
in Portuguese
| LILACS
| ID: lil-47712
ABSTRACT
Os autores apresentam um caso de lúpus-símile induzido por procainamida, com sinais, sintomas e provas laboratoriais característicos desta síndrome. Comentam a fisiopatogenia, bem como o tratamento
Subject(s)
Humans , Lupus Erythematosus, Systemic/chemically induced , Procainamide/adverse effects , Lupus Erythematosus, Systemic/therapy
5.
Indian Heart J
;
1968 Oct; 20(4): 451-62
Article
in English
| IMSEAR
| ID: sea-3001
Subject(s)
Abnormalities, Drug-Induced , Analgesics/adverse effects , Anti-Arrhythmia Agents/adverse effects , Anti-Bacterial Agents/adverse effects , Antidepressive Agents/adverse effects , Antihypertensive Agents/adverse effects , Antimetabolites/adverse effects , Antineoplastic Agents/adverse effects , Arrhythmias, Cardiac/chemically induced , Arteritis/chemically induced , Atropa belladonna/adverse effects , Cardiovascular Diseases/chemically induced , Central Nervous System Stimulants/adverse effects , Clofibrate/adverse effects , Coronary Disease/chemically induced , Digitalis Glycosides/adverse effects , Drug Therapy/adverse effects , Emetine/adverse effects , Female , Heart Defects, Congenital/chemically induced , Heart Diseases/chemically induced , Humans , Hypertension/chemically induced , Hypoglycemic Agents/adverse effects , Iatrogenic Disease , Phenothiazines/adverse effects , Plants, Medicinal , Plants, Toxic , Pregnancy , Pregnancy Complications, Cardiovascular/chemically induced , Procainamide/adverse effects , Quinolines/adverse effects , Sulfonamides/adverse effects , Sympatholytics/adverse effects , Sympathomimetics/adverse effects , Tranquilizing Agents/adverse effects
6.
Non-conventional
in Spanish
| LILACS
| ID: lil-113258
ABSTRACT
Analiza la acción farmacológica, efectividad, dosis de administración y efectos colaterales de diversas drogas antiarrítmicas clasificadas del acuerdo a sus efectos electrofisiológicos (quinidina y procainamida, disopiramida, agentes betabloqueantes, mexiletine, amiodarona, y, verapamil), y suelen indicarse para el tratamiento de la insuficiencia cardíaca, las arritmias y los trastornos de conducción en pacientes chagásicos